Saltar al contenido
Portada » Congresos

Congresos

Comunicación Oral – Congreso SEI 2021. imagen

Comunicación Oral – Congreso SEI 2021.

Sergio Gil Manso, Jorge Gallego Valle, Esther Bernaldo de Quiros, Rocio Lopez Esteban, Juan Miguel Gil Jaurena, Ana Pita, Rafael Correa Rocha, Marjorie Pion.

24 de Marzo de 2021

Las enfermedades autoinmunes y el rechazo de trasplantes son patologías asociadas a una desregulación o respuesta indeseada del sistema inmune frente a antígenos propios o del órgano trasplantado.

Logo del Laboratiorio imagen

ABSTRACT: Novel in vivo tracing of the hepatocyte origin of extracellular vesicles in mice with experimental liver disease.

Elena Blázquez-López, Félix Royo, Elena Vázquez-Ogando, Francisco Javier Cubero, Raquel Herrero, Laura Moreno, José A. Lorente, Angel Cogolludo, Rafael Correa, Marjorie Pion, Yulia Nevzorova, Johanna Sierra, Marta Puerto, Ismael Ranz, Agustin Albillos, Jaime Bosch, Rafael Bañares, Jordi Gracia-Sancho, Juan Falcon-Perez, Javier Vaquero

Background and Aims: Most information about hepatocytederived exosomes and extracellular vesicles (EVs) and their role in health and disease derives from cell culture experiments, which do not represent the complexity of whole organisms.

SIMPOSIUM The Trnasplantation Society – THYMUS-DERIVED TREG INFUSION TO PREVENT GRAFT REJECTION IN HEART-TRANSPLANTED CHILDREN: INITIAL EXPLORATION OF A NEW THERAPEUTIC ARSENAL TO BOOST IMMUNE TOLERANCE. imagen

SIMPOSIUM The Trnasplantation Society – THYMUS-DERIVED TREG INFUSION TO PREVENT GRAFT REJECTION IN HEART-TRANSPLANTED CHILDREN: INITIAL EXPLORATION OF A NEW THERAPEUTIC ARSENAL TO BOOST IMMUNE TOLERANCE.

Rafael Correa-Rocha; Esther Bernaldo de Quirós; VerónicaA. Pérez; Maribel Clemente; Juan Miguel Gil-Jaurena; María Teresa González; Marjorie Pion; Giovanna Lombardi; LoriJ. West; Megan Levings.

24 de mayo de 2017

Immune graft rejection is the main obstacle to successful transplants. Immunosuppressive drugs fail to prevent chronic rejection and also impair the immune system, resulting in reduced lifetime survival rates. Transfer of regulatory T cells (Treg) has acquired growing interest in attempts to achieve indefinite graft survival.